Invention Grant
![Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone](/docs/US/2022-03-08/US11267805B2/abs.jpg.600x600.jpg)
- Patent Title: Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone
-
Application No.: US17006317Application Date: 2020-08-28
-
Publication No.: US11267805B2Publication Date: 2022-03-08
- Inventor: George P. Luke , Stephen Hubbs , Matthew W. Martin , Shawn E. R. Schiller , Robert Wenslow , Yawei Shi , Jun Huang
- Applicant: FORMA Therapeutics, Inc.
- Applicant Address: US MA Watertown
- Assignee: FORMA Therapeutics, Inc.
- Current Assignee: FORMA Therapeutics, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Barnes & Thornburg LLP
- Main IPC: C07D403/10
- IPC: C07D403/10 ; A61K31/665
![Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone](/abs-image/US/2022/03/08/US11267805B2/abs.jpg.150x150.jpg)
Abstract:
The present disclosure reports solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone:
Information query
